Organo Corporation

TSE:6368 Stock Report

Market Cap: JP¥373.1b

Organo Balance Sheet Health

Financial Health criteria checks 4/6

Organo has a total shareholder equity of ¥108.5B and total debt of ¥25.9B, which brings its debt-to-equity ratio to 23.8%. Its total assets and total liabilities are ¥180.8B and ¥72.3B respectively. Organo's EBIT is ¥26.2B making its interest coverage ratio 429. It has cash and short-term investments of ¥16.7B.

Key information

23.8%

Debt to equity ratio

JP¥25.85b

Debt

Interest coverage ratio429x
CashJP¥16.67b
EquityJP¥108.49b
Total liabilitiesJP¥72.33b
Total assetsJP¥180.81b

Recent financial health updates

Organo (TSE:6368) Seems To Use Debt Quite Sensibly

Oct 31
Organo (TSE:6368) Seems To Use Debt Quite Sensibly

Is Organo (TSE:6368) A Risky Investment?

May 10
Is Organo (TSE:6368) A Risky Investment?

Recent updates

Organo (TSE:6368) Has Announced A Dividend Of ¥71.00

Dec 10
Organo (TSE:6368) Has Announced A Dividend Of ¥71.00

Organo Corporation's (TSE:6368) Shares Climb 28% But Its Business Is Yet to Catch Up

Nov 24
Organo Corporation's (TSE:6368) Shares Climb 28% But Its Business Is Yet to Catch Up

Organo (TSE:6368) Seems To Use Debt Quite Sensibly

Oct 31
Organo (TSE:6368) Seems To Use Debt Quite Sensibly

What Does Organo Corporation's (TSE:6368) Share Price Indicate?

Oct 12
What Does Organo Corporation's (TSE:6368) Share Price Indicate?

Organo's (TSE:6368) Dividend Will Be ¥53.00

Sep 23
Organo's (TSE:6368) Dividend Will Be ¥53.00

Under The Bonnet, Organo's (TSE:6368) Returns Look Impressive

Sep 02
Under The Bonnet, Organo's (TSE:6368) Returns Look Impressive

Organo's (TSE:6368) Dividend Will Be ¥53.00

Aug 09
Organo's (TSE:6368) Dividend Will Be ¥53.00

Analysts Are Updating Their Organo Corporation (TSE:6368) Estimates After Its First-Quarter Results

Aug 02
Analysts Are Updating Their Organo Corporation (TSE:6368) Estimates After Its First-Quarter Results

Organo (TSE:6368) Is Due To Pay A Dividend Of ¥53.00

Jul 25
Organo (TSE:6368) Is Due To Pay A Dividend Of ¥53.00

Organo (TSE:6368) Has Announced A Dividend Of ¥53.00

Jul 11
Organo (TSE:6368) Has Announced A Dividend Of ¥53.00

What Organo Corporation's (TSE:6368) P/E Is Not Telling You

Jun 25
What Organo Corporation's (TSE:6368) P/E Is Not Telling You

Is Organo (TSE:6368) A Risky Investment?

May 10
Is Organo (TSE:6368) A Risky Investment?

Returns On Capital Are Showing Encouraging Signs At Organo (TSE:6368)

Apr 25
Returns On Capital Are Showing Encouraging Signs At Organo (TSE:6368)

Organo's (TSE:6368) Dividend Will Be ¥41.00

Mar 25
Organo's (TSE:6368) Dividend Will Be ¥41.00

What Does Organo Corporation's (TSE:6368) Share Price Indicate?

Mar 17
What Does Organo Corporation's (TSE:6368) Share Price Indicate?

Organo Corporation's (TSE:6368) 28% Share Price Surge Not Quite Adding Up

Mar 02
Organo Corporation's (TSE:6368) 28% Share Price Surge Not Quite Adding Up

Organo (TSE:6368) Is Due To Pay A Dividend Of ¥41.00

Feb 27
Organo (TSE:6368) Is Due To Pay A Dividend Of ¥41.00

Financial Position Analysis

Short Term Liabilities: 6368's short term assets (¥151.3B) exceed its short term liabilities (¥64.9B).

Long Term Liabilities: 6368's short term assets (¥151.3B) exceed its long term liabilities (¥7.4B).

Debt to Equity History and Analysis

Debt Level: 6368's net debt to equity ratio (8.5%) is considered satisfactory.

Reducing Debt: 6368's debt to equity ratio has increased from 22.3% to 23.8% over the past 5 years.

Debt Coverage: 6368's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: 6368's interest payments on its debt are well covered by EBIT (429x coverage).

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 18:05
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Organo Corporation is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Takeru AdachiGoldman Sachs
Katsuhiko IshibashiIchiyoshi Research Institute Inc.
Shigekazu IshidaMarusan Securities Co. Ltd.